MaximeLambilliotte

Associate

Brussels + 32.2.645.14.89

Connect:

Share

Maxime Lambilliotte's practice focuses on European competition law and on regulatory matters.

Maxime advises clients on all aspects of competition law at the EU and national levels, including merger control, cartels, anticompetitive agreements, and abuse of dominance. He also experience assisting clients with regulations involving telecoms.

Experience

  • Bombardier sells transportation business to Alstom for €6.2 billionJones Day served as antitrust and French corporate counsel in the €6.2 billion sale of Bombardier Inc.'s transportation business to Alstom S.A.
  • Astellas transfers DIFICLIR in Europe, Middle East, Africa, and selected CIS to Swiss Tillotts Pharma AG for €109 millionJones Day advised Astellas Pharma Europe Ltd. on the sale of distribution rights to the product "DIFICLIR" in Europe, Middle East, Africa, and selected Commonwealth of Independent States (CIS) countries to Swiss Tillotts Pharma AG for €109 million.
  • Qisda completes public tender offer for 19% stake in Alpha NetworksJones Day advised Qisda Corporation (TSE: 2352) in its public tender offer (unsolicited) to purchase up to 103,071,688 common shares (or approximately 19% stake) of Alpha Networks Inc. (TSE: 3380) at NT$30 per share.
  • Materion acquires Optics Balzers, AG for $160 millionJones Day advised Materion Corporation, a global supplier of highly engineered advanced enabling materials, in its $160 million acquisition of Optics Balzers, AG, an industry leader in thin film optical coatings.
  • NVIDIA acquires Mellanox Technologies for approximately $7 billionJones Day advised NVIDIA Corporation in its acquisition of Mellanox Technologies, Ltd., an Israel-based leading supplier of end-to-end InfiniBand and Ethernet interconnect solutions and services for servers and storage.
    • View All

    Before sending, please note:

    Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.